Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC
Status:
Not yet recruiting
Trial end date:
2024-10-10
Target enrollment:
Participant gender:
Summary
The patient wil receive intra- or peritumoral injections of 99mTc-nanocolloid if malignancy
is found during a navigation bronchoscopy. A SPECT/CT-scan will be made to image injections
sites and sentinel lymph nodes (SLN). If surgery takes place to treat the lung cancer, ICG
will be injected and fluorescent lymph nodes will be extensively assessed by a pathologist.